Aravive
initial anti tumor activity from phase trial nab | Aravive
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
31 of 39
Related slides by other companies
MAIA Biotechnology
Investor Presentation
November 2023
thio trial planned a | MAIA Biotechnology
Theravance Biopharma
Results
May 2023
progress against targets | Theravance Biopharma
Kymera
Investor Presentation
August 2023
objectives a a | Kymera
Apollomics
SPAC
September 2022
| Apollomics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights